Literature DB >> 24199031

The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Caitlin M Daimon1, Patrick Chirdon, Stuart Maudsley, Bronwen Martin.   

Abstract

Thyrotropin releasing hormone (TRH) is primarily known as the central regulator of the hypothalamic-pituitary-thyroid (HPT) axis. However, TRH also exerts a variety of central nervous system effects independent from its activity in the HPT axis. With advancing age, decreases in TRH synthesis, expression, and activity have been demonstrated. Associated with this emerging evidence suggests that TRH is implicated in neurodegenerative diseases of aging, including Alzheimer's disease and Parkinson's disease. TRH and its synthetic analogs have been recognized as trophic factors in neurons of the diencephalon and spinal cord, and as neuroprotectants against oxidative stress, glutamate toxicity, caspase-induced cell death, DNA fragmentation, and inflammation. In this review, we will provide an overview of some of the roles of TRH, outside of the HPT axis, associated with pathological aging and neurodegeneration and we shall discuss the potential of TRH and TRH analogs for the treatment of neurodegenerative diseases.

Entities:  

Keywords:  Aging; Alzheimer’s Disease; Neuroprotection; Parkinson’s Disease; Thyrotropin Releasing Hormone

Year:  2013        PMID: 24199031      PMCID: PMC3817016          DOI: 10.7726/ajad.2013.1003

Source DB:  PubMed          Journal:  Am J Alzheimers Dis (Columbia)


  196 in total

Review 1.  Localization of releasing hormones in the human brain.

Authors:  Y Koch; E Okon
Journal:  Int Rev Exp Pathol       Date:  1979

Review 2.  Thyrotropin-axis adaptation in aging and chronic disease.

Authors:  Marius Stan; John C Morris
Journal:  Endocrinol Metab Clin North Am       Date:  2005-12       Impact factor: 4.741

3.  Relationship between thyroid hormone levels and regional cerebral blood flow in Alzheimer disease.

Authors:  Noriyuki Kimura; Toshihide Kumamoto; Hideaki Masuda; Takuya Hanaoka; Yusuke Hazama; Toshio Okazaki; Ryuki Arakawa
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Apr-Jun       Impact factor: 2.703

4.  In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.

Authors:  F Crespi; P E Keane; M Morre
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

5.  TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.

Authors:  K Kinoshita; Y Watanabe; M Yamamura; Y Matsuoka
Journal:  Eur J Pharmacol       Date:  1998-02-19       Impact factor: 4.432

6.  Effects of thyrotropin-releasing hormone and a related analog, CNK-602A, on long-term potentiation in the mossy fiber-CA3 pathway of guinea pig hippocampal slices.

Authors:  K Ishihara; H Katsuki; A Kawabata; M Sasa; M Satoh; S Takaori
Journal:  Brain Res       Date:  1991-07-19       Impact factor: 3.252

7.  Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease.

Authors:  F Javoy-Agid; D Grouselle; A Tixier-Vidal; Y Agid
Journal:  Neuropeptides       Date:  1983-07       Impact factor: 3.286

8.  Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease.

Authors:  Liesbeth A D M van Osch; Eva Hogervorst; Marc Combrinck; A David Smith
Journal:  Neurology       Date:  2004-06-08       Impact factor: 9.910

9.  Sustained release dosage of thyrotropin-releasing hormone improves experimental Japanese encephalitis virus-induced parkinsonism in rats.

Authors:  A Ogata; K Nagashima; K Yasui; T Matsuura; K Tashiro
Journal:  J Neurol Sci       Date:  1998-08-14       Impact factor: 3.181

10.  Neuroendocrinological function in Alzheimer's disease.

Authors:  M Franceschi; L Perego; L Ferini-Strambi; S Smirne; N Canal
Journal:  Neuroendocrinology       Date:  1988-10       Impact factor: 4.914

View more
  11 in total

1.  β-Arrestin2 Is Critically Involved in the Differential Regulation of Phosphosignaling Pathways by Thyrotropin-Releasing Hormone and Taltirelin.

Authors:  Zdenka Drastichova; Radka Trubacova; Jiri Novotny
Journal:  Cells       Date:  2022-04-27       Impact factor: 7.666

2.  Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides.

Authors:  Luca Regazzoni; Laura Fumagalli; Angelica Artasensi; Silvia Gervasoni; Ettore Gilardoni; Angelica Mazzolari; Giancarlo Aldini; Giulio Vistoli
Journal:  Nutrients       Date:  2022-04-23       Impact factor: 6.706

3.  Apolipoprotein E4 Effects a Distinct Transcriptomic Profile and Dendritic Arbor Characteristics in Hippocampal Neurons Cultured in vitro.

Authors:  Jenny R Diaz; Mitchell Martá-Ariza; Alireza Khodadadi-Jamayran; Adriana Heguy; Aristotelis Tsirigos; Joanna E Pankiewicz; Patrick M Sullivan; Martin J Sadowski
Journal:  Front Aging Neurosci       Date:  2022-04-29       Impact factor: 5.702

Review 4.  Unmet needs of patients with narcolepsy: perspectives on emerging treatment options.

Authors:  Dariusz R Wozniak; Timothy G Quinnell
Journal:  Nat Sci Sleep       Date:  2015-05-22

5.  Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals.

Authors:  Zhenwei Shang; Hongchao Lv; Mingming Zhang; Lian Duan; Situo Wang; Jin Li; Guiyou Liu; Zhang Ruijie; Yongshuai Jiang
Journal:  Oncotarget       Date:  2015-12-15

Review 6.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

7.  Brainstem-Evoked Transcription of Defensive Genes After Spinal Cord Injury.

Authors:  Walter J Jermakowicz; Melissa M Carballosa-Gautam; Alberto A Vitores; Ian D Hentall
Journal:  Front Cell Neurosci       Date:  2019-11-19       Impact factor: 5.505

8.  Graves' disease and the risk of Parkinson's disease: a Korean population-based study.

Authors:  Yoon Young Cho; Bongseong Kim; Dong Wook Shin; Jinyoung Youn; Ji Oh Mok; Chul-Hee Kim; Sun Wook Kim; Jae Hoon Chung; Kyungdo Han; Tae Hyuk Kim
Journal:  Brain Commun       Date:  2022-02-07

9.  Neuroprotective effect of total glycosides from paeonies against neurotoxicity induced by strychnos alkaloids related to recovering the levels of neurotransmitters and neuroendocrine hormones in rat serum and brain.

Authors:  Linjia Sun; Yu Chen; Chenzhi Hou; Xiaoyang Sun; Zhipeng Wang; Shujuan Li; Mingming Lv; Xiaohui Chen
Journal:  RSC Adv       Date:  2018-08-16       Impact factor: 4.036

Review 10.  GPCRs Are Optimal Regulators of Complex Biological Systems and Orchestrate the Interface between Health and Disease.

Authors:  Hanne Leysen; Deborah Walter; Bregje Christiaenssen; Romi Vandoren; İrem Harputluoğlu; Nore Van Loon; Stuart Maudsley
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.